PURA Announces Increased EVERx Sales With National Distribution And THC Infused Product Targeted For California And California
April 19 2018 - 8:19AM
InvestorsHub NewsWire
Dallas, TX -- April 19, 2018 -- InvestorsHub
NewsWire -- Puration, Inc. (USOTC:
PURA) today released a scheduled update on the company’s
cannabis infused beverage business. Last year, Puration
introduced EVERx, a CBD infused sports nutrition supplement
line. The sales of EVERx last year yielded over a 60% gross
margin as reported in the company’s 2017 annual report. The initial
sales have won the interest of additional distributors and retail
outlets and in 2018 EVERx sales have already increased.
Management has also targeted the recreational marijuana markets in
California and Canada to introduce a THC Infused product.
More details on the increased EVERx sales and the new THC infused
product are included here in this update.
A Brief History Behind EVERx CBD Infused Sports
Water
Puration introduced EVERx CBD Infused Sports
Water, the first CBD infused sports nutrition supplement product in
an entire line of CBD infused sports nutrition supplement products,
early in 2017. Today, EVERx is a leading brand name for CBD
infused products in the sports nutrition market. Check out
EVERx on Instagram to get a better idea of how well received EVERx
is in the sports nutrition market (https://www.instagram.com/drinkeverx/).
EVERx utilizes a patented technology that breaks
down the hydrogen bonds, reducing water's cluster size, providing a
more efficient delivery system for the highest concentration of CBD
to be found a single bottle of water. EVERx also provides an
optimal alkaline pH level formulated with antioxidants and
electrolytes delivering the most effective hydration available in
the alkaline water market.
- 10 mg Full Spectrum Phytocannabinoids Per 500ml
Bottle
100% THC-free
Maximum Bioavailability
Electrolytes and Antioxidants
BPA Free
Non GMO
EVERx is also available now in Lemon-Lime and
Kiwi-Strawberry.
Growing EVERx Sales
EVERx was first available at Drug Emporium and
online. EVERx has recently been introduced at a major chain
of stores with 170 locations. Puration has also recently
signed a distribution agreement with a national distributor.
Shareholders can expect to see press releases in the coming weeks
with more details on both the new retail outlet for EVERx and the
national distribution contract.
New THC Infused Beverage For California And
Canada
Puration has been working on a THC infused
beverage for the now legal recreational marijuana market in
California, and the recreational marijuana market in Canada
expected to be legalized in July of this year. Today,
Puration announces that is has designed a THC infused beverage and
registered the name THCSavor. Puration has engaged a partner
in Canada for producing and marketing THCSavor and is close to
engaging a production and marketing partner in California.
Shareholders can expect to see press releases in the coming weeks
with more details on the rollout of THCSavor in both Canada and
California.
On Tuesday, earlier this week, Puration
published a shareholder update on the company’s
cannabis cultivation business to include details on a
developing acquisition in Canada. Revenue from the
cultivation business has just gotten started in the first quarter
of 2018 and is anticipated to add to the existing and growing
revenue already resulting from the continuing sales of EVERx.
Keep checking back for further updates on Puration’s business
development progress.
For
more information on EVERx, visit http://www.drinkeverx.com.
For
more information on Puration,
visit http://www.aciconglomerated.com.
Disclaimer/Safe
Harbor:
This
news release contains forward-looking statements within the meaning
of the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
+1-800-861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Sep 2023 to Sep 2024